CN1911328A - Medicine for treating burns and scald - Google Patents
Medicine for treating burns and scald Download PDFInfo
- Publication number
- CN1911328A CN1911328A CN 200510019306 CN200510019306A CN1911328A CN 1911328 A CN1911328 A CN 1911328A CN 200510019306 CN200510019306 CN 200510019306 CN 200510019306 A CN200510019306 A CN 200510019306A CN 1911328 A CN1911328 A CN 1911328A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- rhizoma rhei
- medicine
- oleum camelliae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of ointment for treating burn and scald is prepared from 4 Chinese-medicinal materials including black sanguisorba root, rhubarb, Gypsum rubrum, etc. Its preparing process is also disclosed.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to a kind of medicine for the treatment of empyrosis.
Background technology
Existing treatment burn and scald medicine has tens of kinds, and wherein the prescription medicine is more and roughly the same, treatment by Chinese herbs is extensive use of, but the medicine of existing treatment empyrosis made by multiple medicine, makes complexity and cost height, and treatment cycle is long to leave cicatrix after more.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of empyrosis, this medicine has anti-inflammatory analgetic, infection, granulation promoting, does not stay or stay less the characteristics of cicatrix after healing.
A kind of medicine for the treatment of empyrosis provided by the present invention is made by Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina, Oleum Camelliae.
Its heavy part is as follows:
Radix Sanguisorbae is that 40～30 weight portions, Radix Et Rhizoma Rhei are 25～15 weight portions, Mirabilitum crystallina 25～15 weight portions, Oleum Camelliae 20～10 weight portions.
Manufacture method is as follows:
Take by weighing Radix Sanguisorbae 40～30 weight portions respectively, Radix Et Rhizoma Rhei is 25～15 weight portions, Mirabilitum crystallina 25～15 weight portions, Oleum Camelliae 20～10 weight portions, respectively Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina is ground or breaks into powder, then add Oleum Camelliae and reconcile into pasty state and get final product.
Also the Mirabilitum crystallina of the Radix Et Rhizoma Rhei of the Radix Sanguisorbae of 40～30 weight portions, 25～15 weight portions, 25～15 weight portions can be ground or break into powder, then bottled preservation is got 20～10 weight portion Oleum Camelliae again and is reconciled into pasty state during use.
This Drug therapy cycle is short, has anti-inflammatory analgetic, heat clearing away annealing, infection, granulation promoting, do not stay or stay less the characteristics of cicatrix after healing, and production cost is low, is convenient to investment and production.
The specific embodiment
Embodiment 1
A kind of medicine for the treatment of empyrosis is made by Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina, Oleum Camelliae, and Radix Sanguisorbae is that 40～30 weight portions, Radix Et Rhizoma Rhei are 25～15 weight portions, Mirabilitum crystallina 25～15 weight portions, Oleum Camelliae 20～10 weight portions.
Manufacture method is as follows:
Take by weighing Radix Sanguisorbae 40～30 weight portions respectively, Radix Et Rhizoma Rhei is 25～15 weight portions, Mirabilitum crystallina 25～15 weight portions, Oleum Camelliae 20～10 weight portions, respectively Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina is ground or breaks into powder, then add Oleum Camelliae and reconcile into pasty state and get final product.
Also the Mirabilitum crystallina of the Radix Et Rhizoma Rhei of the Radix Sanguisorbae of 40～30 weight portions, 25～15 weight portions, 25～15 weight portions can be ground or break into powder, then bottled preservation is got 20～10 weight portion Oleum Camelliae again and is reconciled into pasty state during use.
Embodiment 2
A kind of medicine for the treatment of empyrosis is made by Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina, Oleum Camelliae, and Radix Sanguisorbae is that 40 weight portions, Radix Et Rhizoma Rhei are 21 weight portions, Mirabilitum crystallina 21 weight portions, Oleum Camelliae 18 weight portions.
Manufacture method is as follows:
Take by weighing Radix Sanguisorbae 40 weight portions respectively, Radix Et Rhizoma Rhei is 21 weight portions, Mirabilitum crystallina 21 weight portions, Oleum Camelliae 18 weight portions, respectively Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina is ground or breaks into powder, then add Oleum Camelliae and reconcile into pasty state and get final product.
Also the Mirabilitum crystallina of the Radix Et Rhizoma Rhei of the Radix Sanguisorbae of 40 weight portions, 21 weight portions, 21 weight portions can be ground or break into powder, then bottled preservation is got 18 weight portion Oleum Camelliae again and is reconciled into pasty state during use.
Embodiment 3
A kind of medicine for the treatment of empyrosis is made by Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina, Oleum Camelliae,
Its heavy part is as follows:
Radix Sanguisorbae is that 40 grams, Radix Et Rhizoma Rhei are 21 grams, Mirabilitum crystallina 21 grams, Oleum Camelliae 18 grams.
Manufacture method is as follows:
Take by weighing Radix Sanguisorbae 40 gram respectively, Radix Et Rhizoma Rhei is 21 grams, Mirabilitum crystallina 21 grams, Oleum Camelliae 18 grams, respectively Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina are ground or break into powder, then add Oleum Camelliae and reconcile into the medicine that pasty state promptly gets 100 grams, also the Radix Sanguisorbae of 40 grams, the Radix Et Rhizoma Rhei of 21 grams, the Mirabilitum crystallina of 21 grams can be ground or break into powder, then bottled preservation, the Oleum Camelliae of getting Oleum Camelliae 18 grams during use again reconciles into pasty state.Reconcile into pasty state with Oleum Camelliae again during use, after running into accidental burns and scalding, take out standby medicine, clean with clear water earlier and hinder face,, get pasty medicament and be applied to the affected part, change every day and be coated with once, promptly heal in the week as rarely seen local when red and swollen; Should needle earlier during if any vesicle, behind the emptying bleb liquid, directly the medicine dab in hindering face, changed in per two days and to be coated with once, promptly heal in two weeks.
Claims (4)
1, a kind of medicine for the treatment of empyrosis is characterized in that: made by Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina, Oleum Camelliae.
2, a kind of medicine for the treatment of empyrosis according to claim 1 is characterized in that: heavy part of Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina, Oleum Camelliae is as follows: Radix Sanguisorbae is that 40～30 weight portions, Radix Et Rhizoma Rhei are 25～15 weight portions, Mirabilitum crystallina 25～15 weight portions, Oleum Camelliae 20～10 weight portions.
3, a kind of medicine for the treatment of empyrosis according to claim 1, manufacture method is characterized in that: take by weighing Radix Sanguisorbae 40～30 weight portions respectively, Radix Et Rhizoma Rhei is 25～15 weight portions, Mirabilitum crystallina 25～15 weight portions, Oleum Camelliae 20～10 weight portions, respectively Radix Sanguisorbae, Radix Et Rhizoma Rhei, Mirabilitum crystallina are ground or break into powder, then add Oleum Camelliae and reconcile into pasty state and get final product.
4, a kind of medicine for the treatment of empyrosis according to claim 3, it is characterized in that: also the Radix Sanguisorbae of 40～30 weight portions, the Radix Et Rhizoma Rhei of 25～15 weight portions, the Mirabilitum crystallina of 25～15 weight portions can be ground or break into powder, then bottled preservation is got 20～10 weight portion Oleum Camelliae again and is reconciled into pasty state during use.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510019306 CN1911328A (en) | 2005-08-12 | 2005-08-12 | Medicine for treating burns and scald |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510019306 CN1911328A (en) | 2005-08-12 | 2005-08-12 | Medicine for treating burns and scald |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1911328A true CN1911328A (en) | 2007-02-14 |
Family
ID=37720492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510019306 Pending CN1911328A (en) | 2005-08-12 | 2005-08-12 | Medicine for treating burns and scald |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1911328A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101390991B (en) * | 2008-10-27 | 2012-02-15 | 简炳秋 | Medicine for treating coryza, chronic nasal sinusitis |
-
2005
- 2005-08-12 CN CN 200510019306 patent/CN1911328A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101390991B (en) * | 2008-10-27 | 2012-02-15 | 简炳秋 | Medicine for treating coryza, chronic nasal sinusitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1056978C (en) | Method for compounding already prepd. traditional Chinese medicine for external application | |
| CN1911328A (en) | Medicine for treating burns and scald | |
| CN1554373A (en) | Medicine for treating brun and scald and preparing method | |
| CN101129403A (en) | Medicine composite for treating dermatopathy | |
| CN1066944C (en) | Ointment for burn and scald | |
| CN102302595A (en) | Liquid medicine for treating burn | |
| CN1114442C (en) | Burns treating ointment | |
| CN1183925C (en) | External use paste for curing burn, scald and electric shock wound | |
| CN1259948C (en) | External-applying treating liquid for rhinitis and common cold, and its preparation method thereof | |
| CN109331106B (en) | Red medicine preparation for wound repair and preparation method thereof | |
| CN1539463A (en) | Multifunctional health care fluid for nursing skin | |
| CN1238012C (en) | Chinese medicine in the form of spray for treating infection of tonsil | |
| CN1294920C (en) | Medicine prepared with cactus and taraxacum and its prepn. process | |
| CN1060964A (en) | A kind of preparation method of thermal burn medicine | |
| CN1931268A (en) | Acne treating medicine | |
| CN1193778C (en) | Medicine liquid for treating burns and scalds | |
| CN1318392A (en) | Beriberi treating ointment | |
| CN1255128C (en) | Compound toothache health | |
| CN1176710C (en) | Medicine for treating burn and scald and preparation method thereof | |
| CN101129402A (en) | Medicine for treating skin disease | |
| CN1907352A (en) | Outer applying medicine for treating scapulohumeral periarthritis and its preparation process | |
| CN1141795A (en) | Plaster for treatment of various scald | |
| CN1824206A (en) | Medicine for treating gonorrhoea | |
| CN101439168A (en) | Method for preparing medicinal preparation for treating split-hand/split-foot and tinea manus and pedis | |
| CN1157721A (en) | External use liniment for treatment of wart and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20070214 |